Valpromide

Modify Date: 2024-01-05 01:56:50

Valpromide Structure
Valpromide structure
Common Name Valpromide
CAS Number 2430-27-5 Molecular Weight 143.22700
Density 0.885g/cm3 Boiling Point 274.6ºC at 760mmHg
Molecular Formula C8H17NO Melting Point 123-125°C
MSDS Chinese USA Flash Point 119.9ºC
Symbol GHS07
GHS07
Signal Word Warning

 Use of Valpromide


Valpromide is an amide derivative of valproic acid and inhibits human epoxide hydrolase.

 Names

Name valpromide
Synonym More Synonyms

 Valpromide Biological Activity

Description Valpromide is an amide derivative of valproic acid and inhibits human epoxide hydrolase.
Related Catalog
Target

epoxide hydrolase[1]

References

[1]. Pacifici GM, et al. Valpromide inhibits human epoxide hydrolase. Br J Clin Pharmacol. 1986 Sep;22(3):269-74.

[2]. Gorres KL, et al. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus. MBio. 2016 Mar 1;7(2):e00113.

 Chemical & Physical Properties

Density 0.885g/cm3
Boiling Point 274.6ºC at 760mmHg
Melting Point 123-125°C
Molecular Formula C8H17NO
Molecular Weight 143.22700
Flash Point 119.9ºC
Exact Mass 143.13100
PSA 43.09000
LogP 2.38840
Vapour Pressure 0.00535mmHg at 25°C
Index of Refraction 1.44
Storage condition room temp

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YV5965500
CHEMICAL NAME :
Valeramide, 2-propyl-
CAS REGISTRY NUMBER :
2430-27-5
BEILSTEIN REFERENCE NO. :
1750444
LAST UPDATED :
199612
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C8-H17-N-O
MOLECULAR WEIGHT :
143.26
WISWESSER LINE NOTATION :
ZVY3&3

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
890 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
85GNAW "Pharmacodynamie de l'Acide Dipropylacetique (ou Propyl-2-Pentanoique) et de ses Amides," Carraz, G., Imprimerie Eymond, 1968 Volume(issue)/page/year: -,72,1968
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
950 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
85GNAW "Pharmacodynamie de l'Acide Dipropylacetique (ou Propyl-2-Pentanoique) et de ses Amides," Carraz, G., Imprimerie Eymond, 1968 Volume(issue)/page/year: -,71,1968
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
438 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CYLPDN Zhongguo Yaoli Xuebao. Acta Pharmacologica Sinica. Chinese Journal of Pharmacology. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.1- 1980- Volume(issue)/page/year: 9,37,1988 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
600 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
FAATDF Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1981- Volume(issue)/page/year: 6,669,1986

 Safety Information

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H302
Hazard Codes Xn
Risk Phrases R22
Safety Phrases S22-S36/37
RIDADR NONH for all modes of transport
RTECS YV5965500
HS Code 2924199090

 Customs

HS Code 2924199090
Summary 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

 Articles29

More Articles
The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells.

Int. J. Oncol. 47 , 343-52, (2015)

High-risk neuroblastoma remains one of the most important therapeutic challenges for pediatric oncologists. New agents or regimens are urgently needed to improve the treatment outcome of this fatal tu...

Amidic modification of valproic acid reduces skeletal teratogenicity in mice.

Birth Defects Res. B Dev. Reprod. Toxicol. 71(1) , 47-53, (2004)

The antiepileptic drug valproic acid (VPA) is well known to cause neural tube and skeletal defects in both humans and animals. The amidic VPA analogues valpromide (VPD) and valnoctamide (VCD) have muc...

Polycomb homologs are involved in teratogenicity of valproic acid in mice.

Birth Defects Res. A Clin. Mol. Teratol. 70(11) , 870-9, (2004)

Valproic acid (VPA) is widely used to treat epilepsy and bipolar disorder and is also a potent teratogen, but its teratogenic mechanisms are unknown. We have attempted to describe a fundamental role o...

 Synonyms

Depamide
2-Propylvaleramide
Valpromide
2,2-Di-n-propylacetamide
Pentanamide,2-propyl
EINECS 219-394-2
MFCD00051534
2-Ethylvaleramide
2-propylpentamide
2,2-BIS(TRIFLUOROMETHYL)PROPANOL
2-propylpentanamide
Dipropylacetamide
Valpramide
Top Suppliers:I want be here



Get all suppliers and price by the below link:

Valpromide suppliers


Price: $66/10mM*1mLinDMSO

Reference only. check more Valpromide price